ATE337333T1 - Ophthalmische arzneimittelzusammenstellung - Google Patents

Ophthalmische arzneimittelzusammenstellung

Info

Publication number
ATE337333T1
ATE337333T1 AT97926223T AT97926223T ATE337333T1 AT E337333 T1 ATE337333 T1 AT E337333T1 AT 97926223 T AT97926223 T AT 97926223T AT 97926223 T AT97926223 T AT 97926223T AT E337333 T1 ATE337333 T1 AT E337333T1
Authority
AT
Austria
Prior art keywords
ophthalmic
present
leu
gly
met
Prior art date
Application number
AT97926223T
Other languages
English (en)
Inventor
Teruo Nishida
Masatsugu Nakamura
Katsuhiko Nakata
Original Assignee
Santen Pharmaceutical Co Ltd
Teruo Nishida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Teruo Nishida filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE337333T1 publication Critical patent/ATE337333T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97926223T 1996-06-26 1997-06-11 Ophthalmische arzneimittelzusammenstellung ATE337333T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16561296A JP3191038B2 (ja) 1996-06-26 1996-06-26 眼科用医薬組成物

Publications (1)

Publication Number Publication Date
ATE337333T1 true ATE337333T1 (de) 2006-09-15

Family

ID=15815677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926223T ATE337333T1 (de) 1996-06-26 1997-06-11 Ophthalmische arzneimittelzusammenstellung

Country Status (7)

Country Link
US (1) US6221846B1 (de)
EP (1) EP0914827B1 (de)
JP (1) JP3191038B2 (de)
AT (1) ATE337333T1 (de)
DE (1) DE69736554T2 (de)
ES (1) ES2268730T3 (de)
WO (1) WO1997049419A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69923998T2 (de) * 1998-12-09 2006-04-27 Chiron Corp., Emeryville Verwendung eines neurologischen wirkstoffes zur herstellung eines medikamentes zur behandlung von erkrankungen des zentralen nervensystems
US7273618B2 (en) 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
AU7776701A (en) * 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
JP4253743B2 (ja) * 2001-12-03 2009-04-15 輝夫 西田 新規ペプチドおよびその医薬用途
JP4313033B2 (ja) 2002-12-27 2009-08-12 株式会社日本点眼薬研究所 眼科用治療組成物
US20070154448A1 (en) * 2005-11-22 2007-07-05 Ted Reid Methods and compositions using Substance P to promote wound healing
NZ599517A (en) * 2009-09-25 2013-07-26 Santen Pharmaceutical Co Ltd Eye drops containing a partial peptide of an insulin-like groth factor I (FGLM) and a tetrapeptide (SSSR)
CN102612373B (zh) * 2009-11-11 2016-03-02 国立大学法人山口大学 消化器官疾病治疗剂
KR101549639B1 (ko) 2014-11-07 2015-09-03 신지혜 스틱
EP3262060B1 (de) * 2015-02-25 2019-12-25 MacKay Memorial Hospital Peptiden zur verwendung bei der verbeugung oder behandlung der trockene augen
KR101869783B1 (ko) * 2016-08-17 2018-06-22 (주)진셀팜 미백 활성이 우수한 펩타이드, 및 이의 용도
WO2019061491A1 (en) * 2017-09-30 2019-04-04 Pro Sunfun Biotech Research And Development Co., Ltd. PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF
CN109912685B (zh) * 2017-12-13 2022-05-06 三凡生技研发股份有限公司 眼睛保护胜肽及其组合物及使用该胜肽的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
EP0176436A3 (de) 1984-09-26 1987-12-16 Merck & Co. Inc. Analoge der Verbindung P und von Eledoisin
US4885163A (en) 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5104787A (en) 1990-03-05 1992-04-14 Lindstrom Richard L Method for apparatus for a defined serumfree medical solution useful for corneal preservation
US5616562A (en) * 1990-04-27 1997-04-01 Murphy; Christopher J. Methods and compositions using substance P to promote wound healing
GB9113219D0 (en) * 1991-06-19 1991-08-07 Fujisawa Pharmaceutical Co Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
JPH0525001A (ja) 1991-07-08 1993-02-02 L Lyndstrom Richard 血清不含有医療用溶液および眼組織の品質を高める方法
US6310040B1 (en) 1991-11-08 2001-10-30 Cephalon, Inc. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
US5545617A (en) 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion

Also Published As

Publication number Publication date
ES2268730T3 (es) 2007-03-16
JP3191038B2 (ja) 2001-07-23
EP0914827B1 (de) 2006-08-23
WO1997049419A1 (fr) 1997-12-31
DE69736554D1 (de) 2006-10-05
EP0914827A1 (de) 1999-05-12
DE69736554T2 (de) 2007-08-23
US6221846B1 (en) 2001-04-24
EP0914827A4 (de) 1999-08-04
JPH1017489A (ja) 1998-01-20

Similar Documents

Publication Publication Date Title
DE69736554D1 (de) Ophthalmische arzneimittelzusammenstellung
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
HUP0102899A2 (hu) Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
BR0214757A (pt) Formulações farmacêuticas de derivados de platina
BR9107124A (pt) Novos derivados de acido hidroxamico e de n-hidroxiureia e seu uso
NO975962L (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
DE69521688D1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69229318D1 (de) Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
ATE218868T1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ATE245900T1 (de) Pour-on formulierung enthaltend polymerische material, glykole und glyzeriden
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
HUP9802897A2 (hu) Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
ATE458471T1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
US5993841A (en) Pharmaceutical composition and methods for using it
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
NO950177L (no) Farmakologisk aktive erivater
TR200201654T2 (tr) Benzamidin türevleri.
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties